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Introduction: Arterial spin labeling (ASL) is a powerful tool for the non-
invasive assessment of tissue perfusion. In the human heart, however, mea-
suring myocardial perfusion (MBF) is challenging due to strong physiological
noise. Steady-pulsed ASL (spASL) under free-breathing had been proposed to
improve sensitivity. To improve robustness against respiratory motion, effi-
ciency and spatial resolution, we present an optimization of the post-
processing algorithm by way of a dedicated motion correction (Moco).
Methods: The spASL sequence was implemented on a Siemens 3T Verio
system, based on an ECG-triggered bSSFP acquisition combined with a slice-
selective labeling module. ASL was performed at each cardiac cycle to drive
tissue magnetization into a perfusion-dependent steady-state. The spASL acquisi-
tion was repeated 128 times to accumulate data and a customized 2-step Moco
was carried out. First, global correction in a large ROI was performed by spatially
shifting every image and minimizing signal difference with a reference. Then, a
more precise regional correction based on contour correlation was used.
Results: When performing global correction, MBF mapping was possible.
Fig.1 shows a comparison between two maps in a volunteer without and with
Moco. Better homogeneity and delineation of the myocardium can be seen.
Using the 2nd described step before carrying out the quantification in myocar-
dial regions led to improved signal stability. Without Moco, signal was found
stable when including up to 30% of all images. With Moco, the signal reached
a plateau around 50% and remained stable until 80% of included images.
Conclusion: With this new approach, a greater portion (80% versus 30%
formerly) of the acquired data can be used for regional perfusion assessment.
This work is also a step towards calculation of myocardial perfusion maps
with high spatial resolution using ASL.
Abstract 0411 – Figure: MBF maps obtained with spASL MRI
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Enhancing the contour of stent: a new tool in the optimization of out-
come of coronary angioplasty
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Background: The deployment of coronary stents reduces the rate of TLR
(Target Lesion Revascularization), subacute stent thrombosis and restenosis. .
The enhancement contour of stent recently developed by GE Healthcare on
Innova 2100 (StentViz) improves the analysis of the structure of the stent and
evaluates its positioning and deployment.
Objectives: The purpose of our study was to clarify the feasibility of StentViz,
its advantages and limitations, and the predictors of good image quality.
Patients and methods: We conducted a prospective study between Jan-
uary and April 2011 from a series of 50 stented lesions in patients re-vascu-
larized on the native vessels in the cardiology department of the Val-de-Grace
Military Hospital. For each procedure, the protocol consisted to successively
perform an angiogram after placement of the stent, and a stentViz. Then we
compared in single blind, angiogram and StentViz results, using a quality
scale (1: stent invisible; 2: stent edge guessed; 3: edge stent visible; 4: edge
stent visible and visible stitches).
Results: In 49 cases, analysis of the angiogram was done (98%). It showed a
defect of deployment in 27 lesions (54%).The quality score was 26% of cases
equal to 2; 38% equal to 3  and 36% equal to 4.; In 42 cases, analysis of 1 stentViz
was usable (84%). It showed a lack of deployment in 34 lesions (68%).The quality
score was 14% equals to 1, 8% equals to 2. 18% equals to 3 and 60% of cases
equal to 4.The failure of stentViz, defined as nonvisible stent and / or impossible
analysis of deployment was observed in 8 cases. The poor results are obtained on
the lesions of the LAD and Circumflex with a failure rate of 20% and 14.2%,
while that rate is 12.5% on the right coronary. Statistical analysis showed that the
stentViz detects more default deployment than angiography in14% of procedure
(p 0.039).The post expansion was retained in 54% of cases.
Conclusion: The edge enhancement stent represents a new tool in optimizing
the outcome of coronary angioplasty. The StentViz developed by GE™ provides
8 out of 10 interpretable image quality. It finds his place in the analysis of stent
deployment without increased risk and no additional cost.
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Introduction: Cardiovascular disease is the first leading cause of death in
hemodialysis patients. In this population, cardiovascular calcifications occur at
an earlier age and progress faster than in general population.
Patients and methods: In order to determine the prevalence and risk fac-
tors of cardiac calcifications, 49 patients on chronic hemodialysis were
screened in the coronary arteries and cardiac valves by the 64 multislice ultra-
fast CT and the transthoracic echocardiography. Different clinical and biolog-
ical parameters were studied by the SPSS 10.0 statistical software to deter-
mine risk factors.
Result: Cardiac calcifications were identified in 81.6% of cases in at least
one of the two studied sites. The coronary artery involvement was more
common than valvular and concerned 69.4% of cases. The mean Agatston cor-
onary artery calcium score (ACACS) was 331.1 and 522.2 in coronary
patients and was correlated to alteration of systolic function of LV (r=–0,287,
p=0,045). The severity of CACS was positively correlated with age (r=0.332,
p=0.02). Coronary calcifications were associated with cardiovascular risk
common to those of the general population (age, male sex, systolic blood pres-
sure, diabetes, history of ischemic heart disease), but also to a lesser quality
of dialysis. Valvular calcifications were prent in 49% of cases and were cor-
related with left ventricular hypertrophy (p 0.006). The exclusive involvement
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